Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations

When a small molecule binds to the androgen receptor (AR), a conformational change can occur which impacts subsequent binding of co-regulator proteins and DNA. In order to accurately study this mechanism, the scientific community needs a crystal structure of the Wild type AR (WT-AR) ligand binding d...

Full description

Bibliographic Details
Main Authors: Sugunadevi Sakkiah, Rebecca Kusko, Bohu Pan, Wenjing Guo, Weigong Ge, Weida Tong, Huixiao Hong
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2018.00492/full
_version_ 1811304114100895744
author Sugunadevi Sakkiah
Rebecca Kusko
Bohu Pan
Wenjing Guo
Weigong Ge
Weida Tong
Huixiao Hong
author_facet Sugunadevi Sakkiah
Rebecca Kusko
Bohu Pan
Wenjing Guo
Weigong Ge
Weida Tong
Huixiao Hong
author_sort Sugunadevi Sakkiah
collection DOAJ
description When a small molecule binds to the androgen receptor (AR), a conformational change can occur which impacts subsequent binding of co-regulator proteins and DNA. In order to accurately study this mechanism, the scientific community needs a crystal structure of the Wild type AR (WT-AR) ligand binding domain, bound with antagonist. To address this open need, we leveraged molecular docking and molecular dynamics (MD) simulations to construct a structure of the WT-AR ligand binding domain bound with antagonist bicalutamide. The structure of mutant AR (Mut-AR) bound with this same antagonist informed this study. After molecular docking analysis pinpointed the suitable binding orientation of a ligand in AR, the model was further optimized through 1 μs of MD simulations. Using this approach, three molecular systems were studied: (1) WT-AR bound with agonist R1881, (2) WT-AR bound with antagonist bicalutamide, and (3) Mut-AR bound with bicalutamide. Our structures were very similar to the experimentally determined structures of both WT-AR with R1881 and Mut-AR with bicalutamide, demonstrating the trustworthiness of this approach. In our model, when WT-AR is bound with bicalutamide, Val716/Lys720/Gln733, or Met734/Gln738/Glu897 move and thus disturb the positive and negative charge clumps of the AF2 site. This disruption of the AF2 site is key for understanding the impact of antagonist binding on subsequent co-regulator binding. In conclusion, the antagonist induced structural changes in WT-AR detailed in this study will enable further AR research and will facilitate AR targeting drug discovery.
first_indexed 2024-04-13T08:00:07Z
format Article
id doaj.art-8205112e8e1c41a4baf1f4722ddcc68c
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T08:00:07Z
publishDate 2018-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-8205112e8e1c41a4baf1f4722ddcc68c2022-12-22T02:55:17ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-05-01910.3389/fphar.2018.00492329304Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics SimulationsSugunadevi Sakkiah0Rebecca Kusko1Bohu Pan2Wenjing Guo3Weigong Ge4Weida Tong5Huixiao Hong6Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United StatesImmuneering Corporation, Cambridge, MA, United StatesDivision of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United StatesDivision of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United StatesDivision of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United StatesDivision of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United StatesDivision of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United StatesWhen a small molecule binds to the androgen receptor (AR), a conformational change can occur which impacts subsequent binding of co-regulator proteins and DNA. In order to accurately study this mechanism, the scientific community needs a crystal structure of the Wild type AR (WT-AR) ligand binding domain, bound with antagonist. To address this open need, we leveraged molecular docking and molecular dynamics (MD) simulations to construct a structure of the WT-AR ligand binding domain bound with antagonist bicalutamide. The structure of mutant AR (Mut-AR) bound with this same antagonist informed this study. After molecular docking analysis pinpointed the suitable binding orientation of a ligand in AR, the model was further optimized through 1 μs of MD simulations. Using this approach, three molecular systems were studied: (1) WT-AR bound with agonist R1881, (2) WT-AR bound with antagonist bicalutamide, and (3) Mut-AR bound with bicalutamide. Our structures were very similar to the experimentally determined structures of both WT-AR with R1881 and Mut-AR with bicalutamide, demonstrating the trustworthiness of this approach. In our model, when WT-AR is bound with bicalutamide, Val716/Lys720/Gln733, or Met734/Gln738/Glu897 move and thus disturb the positive and negative charge clumps of the AF2 site. This disruption of the AF2 site is key for understanding the impact of antagonist binding on subsequent co-regulator binding. In conclusion, the antagonist induced structural changes in WT-AR detailed in this study will enable further AR research and will facilitate AR targeting drug discovery.http://journal.frontiersin.org/article/10.3389/fphar.2018.00492/fullandrogen receptormolecular dynamics simulationsinduced molecular dockingbicalutamideagonistantagonist
spellingShingle Sugunadevi Sakkiah
Rebecca Kusko
Bohu Pan
Wenjing Guo
Weigong Ge
Weida Tong
Huixiao Hong
Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations
Frontiers in Pharmacology
androgen receptor
molecular dynamics simulations
induced molecular docking
bicalutamide
agonist
antagonist
title Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations
title_full Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations
title_fullStr Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations
title_full_unstemmed Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations
title_short Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations
title_sort structural changes due to antagonist binding in ligand binding pocket of androgen receptor elucidated through molecular dynamics simulations
topic androgen receptor
molecular dynamics simulations
induced molecular docking
bicalutamide
agonist
antagonist
url http://journal.frontiersin.org/article/10.3389/fphar.2018.00492/full
work_keys_str_mv AT sugunadevisakkiah structuralchangesduetoantagonistbindinginligandbindingpocketofandrogenreceptorelucidatedthroughmoleculardynamicssimulations
AT rebeccakusko structuralchangesduetoantagonistbindinginligandbindingpocketofandrogenreceptorelucidatedthroughmoleculardynamicssimulations
AT bohupan structuralchangesduetoantagonistbindinginligandbindingpocketofandrogenreceptorelucidatedthroughmoleculardynamicssimulations
AT wenjingguo structuralchangesduetoantagonistbindinginligandbindingpocketofandrogenreceptorelucidatedthroughmoleculardynamicssimulations
AT weigongge structuralchangesduetoantagonistbindinginligandbindingpocketofandrogenreceptorelucidatedthroughmoleculardynamicssimulations
AT weidatong structuralchangesduetoantagonistbindinginligandbindingpocketofandrogenreceptorelucidatedthroughmoleculardynamicssimulations
AT huixiaohong structuralchangesduetoantagonistbindinginligandbindingpocketofandrogenreceptorelucidatedthroughmoleculardynamicssimulations